Warfarin prophylaxis in patients after total knee or hip arthroplasty international normalized ratio patterns and venous thromboembolism

Current Medical Research and Opinion

Volumn 27, Issue 10, 2011, Pages 1973-1985

  Nordstrom, Beth L ^a   Kachroo, Sumesh ^a   Fraeman, Kathy H ^a   Nutescu, Edith A ^b   Schein, Jeff R ^c   Fisher, Alan ^c   Bookhart, Brahim K ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Guideline adherence; Hip arthroplasty; International normalized ratio; Knee arthroplasty; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PENNSYLVANIA; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 80053034122     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.614938     Document Type: Article

References (24)

1. Mehrotra C, Remington PL, Naimi TS, et al. Trends in total knee replacement surgeries and implications for public health, 1990-2000. Public Health Rep 2005;120:278-82 (Pubitemid 40631538)
2. Iorio R, Robb WJ, Healy WL, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am 2008;90:1598-605 (Pubitemid 351947604)
3. Lee K, Goodman SB. Current state and future of joint replacements in the hip and knee. Expert Rev Med Devices 2008;5:383-93
4. Sharkey PF, Sethuraman V, Hozack WJ, et al. Factors influencing choice of implants in total hip arthroplasty and total knee arthroplasty: perspectives of surgeons and patients. J Arthroplasty 1999;14:281-7 (Pubitemid 29172242)
5. Pulido L, Parvizi J, Macgibeny M, et al. In hospital complications after total joint arthroplasty. J Arthroplasty 2008;23:139-45
6. Michota FA. Prevention of venous thromboembolism after surgery. Cleve Clin J Med 2009;76(Suppl 4):S45-S52
7. Pulido L, Grossman S, Smith EB, et al. Clinical presentation of pulmonary embolus after total joint arthroplasty: do size and location of embolus matter? Am J Orthop (Belle Mead NJ) 2010;39:185-9
8. National quality forum endorses consensus standards for quality of hospital care. May 15, 2008. Available at: http://www.prnewswire.com/news- releases/national-quality-forum-endorses-consensus-standards-for-quality-of- hospitalcare-57256902.html [Last accessed 20 May 2011]
9. Ansari S, Warwick D, Ackroyd CE, et al. Incidence of fatal pulmonary embolism after 1,390 knee arthroplasties without routine prophylactic anticoagulation, except in high-risk cases. J Arthroplasty 1997;12:599-602 (Pubitemid 27427937)
10. Warwick DJ, Whitehouse S. Symptomatic venous thromboembolism after total knee replacement. J Bone Joint Surg Br 1997;79:780-6 (Pubitemid 27434498)
11. Warwick D, Bannister GC, Glew D, et al. Perioperative low-molecular-weight heparin. Is it effective and safe. J Bone Joint Surg Br 1995;77:715-19
12. Callaghan JJ, Warth LC, Hoballah JJ, et al. Evaluation of deep venous thrombosis prophylaxis in low-risk patients undergoing total knee arthroplasty. J Arthroplasty 2008;23:20-4
13. Messieh M, Huang Z, Johnson LJ, et al. Warfarin responses in total joint and hip fracture patients. J Arthroplasty 1999;14:724-9 (Pubitemid 29448788)
14. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th edn. Chest 2008;133:381S-453S (Pubitemid 351894916)
15. American Academy of Orthopaedic Surgeons. American Academy of Orthopaedic Surgeons clinical guideline on prevention of pulmonary embolism in patients undergoing total hip or knee arthroplasty. May 2007. Available at: www.aaos.org/Research/guidelines/PE-guideline.pdf [Last accessed 20 May 20 2011]
16. Eikelboom JW, Karthikeyan G, Fagel N, et al. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest 2009;135:513-20
17. Haas SB, Barrack RL, Westrich G, et al. Venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 2008;90:2764-80
18. Herout PM, Harshaw Q, Phatak H, et al. Impact of worsening renal function during hospital admission on resource utilization in patients with heart failure. Am J Cardiol 2010;106:1139-45
19. Asche C, Nelson R, McAdam-Marx C, et al. Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int 2010;21:1427-36
20. Rosendaal FR, Cannegieter SC, van der Meer FJ, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-9 (Pubitemid 23069000)
21. Oake N, Jennings A, Forster AJ, et al. Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ 2008;179:235-44
22. White RH, Henderson MC. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Curr Opin Pulm Med 2002;8:365-71 (Pubitemid 34836938)
23. Warwick D, Friedman RJ, Agnelli G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br 2007;89:799-807 (Pubitemid 47180202)
24. Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279:458-62 (Pubitemid 28082257)